By expenditures
| Name | Title | Type |
|---|---|---|
| William L. Hill, II | VP FOR FINANCE AND ADMINISTRATION | Auditee |
| Andrea Caladie | Audit Principal | Auditee |
| Joseph Sassa | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 341151 | 2024 | 2025-02-04 | Baker Tilly US LLP | $8.51M |
| 293097 | 2023 | 2024-03-01 | Baker Tilly US LLP | $7.90M |
| 35306 | 2022 | 2023-02-13 | Baker Tilly US LLP | $7.43M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 293097 | 2023 | 2024-03-01 | 947862 | 2023-002 | Significant Deficiency | - | N |
| 293097 | 2023 | 2024-03-01 | 947861 | 2023-001 | Significant Deficiency | - | N |
| 293097 | 2023 | 2024-03-01 | 947860 | 2023-002 | Significant Deficiency | - | N |
| 293097 | 2023 | 2024-03-01 | 947859 | 2023-001 | Significant Deficiency | - | N |
| 293097 | 2023 | 2024-03-01 | 947858 | 2023-002 | Significant Deficiency | - | N |
| 293097 | 2023 | 2024-03-01 | 371420 | 2023-002 | Significant Deficiency | - | N |
| 293097 | 2023 | 2024-03-01 | 371419 | 2023-001 | Significant Deficiency | - | N |
| 293097 | 2023 | 2024-03-01 | 371418 | 2023-002 | Significant Deficiency | - | N |
| 293097 | 2023 | 2024-03-01 | 371417 | 2023-001 | Significant Deficiency | - | N |
| 293097 | 2023 | 2024-03-01 | 371416 | 2023-002 | Significant Deficiency | - | N |
| 35306 | 2022 | 2023-02-13 | 609916 | 2022-003 | Significant Deficiency | Yes | N |
| 35306 | 2022 | 2023-02-13 | 609915 | 2022-001 | Significant Deficiency | - | N |
| 35306 | 2022 | 2023-02-13 | 609914 | 2022-003 | Significant Deficiency | Yes | N |
| 35306 | 2022 | 2023-02-13 | 609913 | 2022-002 | Significant Deficiency | - | L |
| 35306 | 2022 | 2023-02-13 | 33474 | 2022-003 | Significant Deficiency | Yes | N |
| 35306 | 2022 | 2023-02-13 | 33473 | 2022-001 | Significant Deficiency | - | N |
| 35306 | 2022 | 2023-02-13 | 33472 | 2022-003 | Significant Deficiency | Yes | N |
| 35306 | 2022 | 2023-02-13 | 33471 | 2022-002 | Significant Deficiency | - | L |